EP0891349A4 - Inhibitors of farnesyl-protein transferase - Google Patents
Inhibitors of farnesyl-protein transferaseInfo
- Publication number
- EP0891349A4 EP0891349A4 EP97917599A EP97917599A EP0891349A4 EP 0891349 A4 EP0891349 A4 EP 0891349A4 EP 97917599 A EP97917599 A EP 97917599A EP 97917599 A EP97917599 A EP 97917599A EP 0891349 A4 EP0891349 A4 EP 0891349A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- farnesyl
- inhibitors
- protein transferase
- transferase
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1458796P | 1996-04-03 | 1996-04-03 | |
US14587P | 1996-04-03 | ||
GB9613461 | 1996-06-27 | ||
GBGB9613461.4A GB9613461D0 (en) | 1996-06-27 | 1996-06-27 | Inhibitors of farnesyl-protein transferase |
PCT/US1997/004711 WO1997036888A1 (en) | 1996-04-03 | 1997-03-27 | Inhibitors of farnesyl-protein transferase |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0891349A1 EP0891349A1 (en) | 1999-01-20 |
EP0891349A4 true EP0891349A4 (en) | 2001-01-24 |
Family
ID=26309576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP97917599A Withdrawn EP0891349A4 (en) | 1996-04-03 | 1997-03-27 | Inhibitors of farnesyl-protein transferase |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0891349A4 (en) |
JP (1) | JP2000507576A (en) |
AU (1) | AU715667B2 (en) |
CA (1) | CA2249604A1 (en) |
WO (1) | WO1997036888A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1090012A4 (en) | 1998-07-02 | 2005-04-06 | Merck & Co Inc | Inhibitors of prenyl-protein transferase |
USRE39921E1 (en) | 1999-10-07 | 2007-11-13 | Smithkline Beecham Corporation | Chemical compounds |
GB9923748D0 (en) | 1999-10-07 | 1999-12-08 | Glaxo Group Ltd | Chemical compounds |
CA2774959C (en) | 2000-08-04 | 2016-05-31 | Dmi Biosciences, Inc. | Method of using diketopiperazines and composition containing them |
US6967202B2 (en) | 2000-08-04 | 2005-11-22 | Dmi Biosciences, Inc. | Method of synthesizing diketopiperazines |
GB0025354D0 (en) | 2000-10-17 | 2000-11-29 | Glaxo Group Ltd | Chemical compounds |
AU2003244455A1 (en) | 2002-02-08 | 2003-09-02 | Glaxo Group Limited | Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases |
GB0203020D0 (en) | 2002-02-08 | 2002-03-27 | Glaxo Group Ltd | Chemical compounds |
GB0203022D0 (en) | 2002-02-08 | 2002-03-27 | Glaxo Group Ltd | Chemical compounds |
PT2537524T (en) | 2003-05-15 | 2016-09-05 | Ampio Pharmaceuticals Inc | Treatment of t-cell mediated diseases |
WO2009146320A1 (en) | 2008-05-27 | 2009-12-03 | Dmi Life Sciences, Inc. | Therapeutic methods and compounds |
EP2613786A4 (en) | 2010-09-07 | 2013-10-23 | Dmi Acquisition Corp | Treatment of diseases |
MY167804A (en) | 2011-10-10 | 2018-09-26 | Ampio Pharmaceuticals Inc | Treatment of degenerative joint disease |
EP2765968A4 (en) | 2011-10-10 | 2015-01-21 | Ampio Pharmaceuticals Inc | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
JP6231484B2 (en) | 2011-10-28 | 2017-11-15 | アンピオ ファーマシューティカルズ,インコーポレイテッド | Rhinitis treatment |
CA2906864A1 (en) | 2013-03-15 | 2014-09-18 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
JP6723222B2 (en) | 2014-08-18 | 2020-07-15 | アンピオ ファーマシューティカルズ,インコーポレイテッド | Treatment of joint pathology |
EP3310375A4 (en) | 2015-06-22 | 2019-02-20 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
WO2021195265A1 (en) | 2020-03-24 | 2021-09-30 | Ampio Pharmaceuticals, Inc. | Methods for treating diseases associated with respiratory viruses |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54106481A (en) * | 1978-02-08 | 1979-08-21 | Toyama Chem Co Ltd | Novel 2,3-dioxopiperazine derivative and its preparation |
JPS61233675A (en) * | 1985-03-26 | 1986-10-17 | Fujisawa Pharmaceut Co Ltd | Piperazine compound |
WO1995000497A1 (en) * | 1993-06-18 | 1995-01-05 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
EP0670314A1 (en) * | 1993-09-22 | 1995-09-06 | Kyowa Hakko Kogyo Co., Ltd. | Farnesyltransferase inhibitor |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4287195A (en) * | 1978-07-14 | 1981-09-01 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of [4-(piperazin-1-yl-phenyloxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazoles and 1H-1,2,4-triazoles |
US4456605A (en) * | 1981-05-07 | 1984-06-26 | Janssen Pharmaceutica N.V. | Heterocyclic derivatives of [4-(piperazin-1-yl-phenyloxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazoles and 1H-1,2,4-triazoles |
US5478934A (en) * | 1994-11-23 | 1995-12-26 | Yuan; Jun | Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands |
-
1997
- 1997-03-27 AU AU25875/97A patent/AU715667B2/en not_active Ceased
- 1997-03-27 EP EP97917599A patent/EP0891349A4/en not_active Withdrawn
- 1997-03-27 JP JP9535347A patent/JP2000507576A/en active Pending
- 1997-03-27 WO PCT/US1997/004711 patent/WO1997036888A1/en not_active Application Discontinuation
- 1997-03-27 CA CA002249604A patent/CA2249604A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54106481A (en) * | 1978-02-08 | 1979-08-21 | Toyama Chem Co Ltd | Novel 2,3-dioxopiperazine derivative and its preparation |
JPS61233675A (en) * | 1985-03-26 | 1986-10-17 | Fujisawa Pharmaceut Co Ltd | Piperazine compound |
WO1995000497A1 (en) * | 1993-06-18 | 1995-01-05 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
EP0670314A1 (en) * | 1993-09-22 | 1995-09-06 | Kyowa Hakko Kogyo Co., Ltd. | Farnesyltransferase inhibitor |
Non-Patent Citations (8)
Title |
---|
B. H. CHASE, A. M. DOWNES: "The Synthesis of (14)C-Labelled Diethylcarbamazine, 1-Diethylcarbamyl-4-methylpiperazine ("Hetrazan")", J. CHEM. SOC., 1953, pages 3874 - 3877, XP000943297 * |
N. SHIMAZAKI ET AL.: "Diketopiperazine derivatives, a new synthesis of platelet-activating factor inhibitors", CHEM. PHARM. BULL., vol. 35, no. 8, 1987, pages 3527 - 3530, XP000941477 * |
PATENT ABSTRACTS OF JAPAN vol. 003, no. 128 24 October 1979 (1979-10-24) * |
PATENT ABSTRACTS OF JAPAN vol. 011, no. 080 11 March 1998 (1998-03-11) * |
See also references of WO9736888A1 * |
T. D. HARRIS ET AL.: "An Improved Synthesis of 1-Methyl-2,5-piperazinedione", J. HETEROCYCL. CHEM., vol. 18, no. 1, 1981, pages 423 - 424, XP000943271 * |
T. FUKUYAMA ET AL.: "Total synthesis of gliotoxin, dehydrogliotoxin and hyalodendrin", TETRAHEDRON, vol. 37, 1981, pages 2045 - 2078, XP000941476 * |
T. M. WILLIAMS ET AL.: "2-Substituted Piperazines as Constrained Amino Acids. Application to the Synthesis of Potent, Non Carboxylic Acid Inhibitors of Farnesyltransferase", J. MED. CHEM., vol. 39, no. 7, 1996, pages 1345 - 1348, XP002152726 * |
Also Published As
Publication number | Publication date |
---|---|
AU715667B2 (en) | 2000-02-10 |
WO1997036888A1 (en) | 1997-10-09 |
CA2249604A1 (en) | 1997-10-09 |
JP2000507576A (en) | 2000-06-20 |
EP0891349A1 (en) | 1999-01-20 |
AU2587597A (en) | 1997-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0891350A4 (en) | Inhibitors of farnesyl-protein transferase | |
EP1011669A4 (en) | Inhibitors of farnesyl-protein transferase | |
GB9604311D0 (en) | Inhibitors of farnesyl-protein transferase | |
EP0891360A4 (en) | Inhibitors of farnesyl-protein transferase | |
EP1045844A4 (en) | Inhibitors of farnesyl-protein transferase | |
EP0904080A4 (en) | Inhibitors of farnesyl-protein transferase | |
EP0880320A4 (en) | Inhibitors of farnesyl-protein transferase | |
EP0891349A4 (en) | Inhibitors of farnesyl-protein transferase | |
EP0891352A4 (en) | Inhibitors of farnesyl-protein transferase | |
EP1035850A4 (en) | Inhibitors of farnesyl-protein transferase | |
EP1035852A4 (en) | Inhibitors of farnesyl-protein transferase | |
EP0891335A4 (en) | Inhibitors of farnesyl-protein transferase | |
EP0891353A4 (en) | Inhibitors of farnesyl-protein transferase | |
EP0959883A4 (en) | Inhibitors of farnesyl-protein transferase | |
EP1035849A4 (en) | Inhibitors of farnesyl-protein transferase | |
EP0877610A4 (en) | Inhibitors of farnesyl-protein transferase | |
EP1023270A4 (en) | Inhibitors of farnesyl-protein transferase | |
EP0900081A4 (en) | Inhibitors of farnesyl-protein transferase | |
GB9721000D0 (en) | Inhibitors of farnesyl-protein transferase | |
GB9613460D0 (en) | Inhibitors of farnesyl-protein transferase | |
GB9617257D0 (en) | Inhibitors of farnesyl-protein transferase | |
GB9610338D0 (en) | Inhibitors of farnesyl-protein transferase | |
GB9610654D0 (en) | Inhibitors of farnesyl-protein transferase | |
GB9612291D0 (en) | Inhibitors of farnesyl-protein transferase | |
GB9609666D0 (en) | Inhibitors of farnesyl-protein transferase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19981103 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20001206 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20011001 |